DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Jubilant Ingrevia Limited — Press Release

NSE 1 hr ago·22 Jul 2026, 9:03 am

Jubilant Ingrevia

Jubilant Ingrevia Limited has announced the release of its financial results for the quarter ended June 30, 2026. The company has submitted a formal press release and presentation to the stock exchanges detailing its performance during this period. This update provides the market with an official statement regarding the company's current financial standing and operational progress.

For investors, this disclosure is a standard step that offers transparency into the company's recent business activities. It allows stakeholders to review the company's performance metrics and strategy directly from the source. Keeping an eye on the specific figures and commentary within this release will be key to understanding the company's trajectory in the coming quarters.

Investors should monitor the company's commentary on demand trends and cost management. The market will likely react to any guidance provided regarding future performance. Observing how the stock reacts to this information will be the primary indicator of investor sentiment towards Jubilant Ingrevia's near-term outlook.